Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Lenoir O, Tharaux PL. Should we consider calcimimetics as a therapeutic option for nephrotic syndrome? Kidney Int 2022;101:1110-1112. [PMID: 35597590 DOI: 10.1016/j.kint.2022.04.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Revised: 04/06/2022] [Accepted: 04/08/2022] [Indexed: 11/18/2022]

For:	Lenoir O, Tharaux PL. Should we consider calcimimetics as a therapeutic option for nephrotic syndrome? Kidney Int 2022;101:1110-1112. [PMID: 35597590 DOI: 10.1016/j.kint.2022.04.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Revised: 04/06/2022] [Accepted: 04/08/2022] [Indexed: 11/18/2022]

Number

Cited by Other Article(s)

Murtas C, Guastini R, Cristi E, Ranalli TV, Feriozzi S. Cinacalcet in focal segmental glomerular sclerosis: a case report. Kidney Int 2024;105:389-390. [PMID: 38245216 DOI: 10.1016/j.kint.2023.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Revised: 09/12/2023] [Accepted: 10/20/2023] [Indexed: 01/22/2024]